Patents by Inventor David A. Hosford

David A. Hosford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230115901
    Abstract: One embodiment provides a method, including: receiving, at an information handling device, an indication to backup data resident on an operating system (OS) partition of the information handling device; initiating, responsive to receiving the indication, a reboot of the OS into a pre-OS environment; accessing, in the pre-OS environment, a backup partition that is distinct and separate from the OS partition; and performing, subsequent to the accessing, a backup of the data from the OS partition to the backup partition. Other aspects are described and claimed.
    Type: Application
    Filed: September 30, 2021
    Publication date: April 13, 2023
    Inventors: David Rivera, Joshua N. Novak, Matthew David Hosford
  • Publication number: 20140024638
    Abstract: The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions, and methods for treating schizophrenia.
    Type: Application
    Filed: January 17, 2012
    Publication date: January 23, 2014
    Applicant: TARGACEPT, INC.
    Inventors: Merouane Bencherif, Geoffrey C. Dunbar, David A. Hosford, Gregory J. Gatto, Terry Hauser, Kristen G. Jordan, Anthony Carl Segreti
  • Patent number: 8569381
    Abstract: The present invention includes a combination comprising: a) mecamylamine; and b) an ACE inhibitor, an AT2 receptor inhibitor, a renin inhibitor, or a combination thereof.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: October 29, 2013
    Assignee: Targacept, Inc.
    Inventors: Steven M. Toler, David A. Hosford
  • Publication number: 20130237550
    Abstract: The present invention relates to method of treating constipation and enhancing colonic motility by administration of 5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 4, 2011
    Publication date: September 12, 2013
    Applicant: TARGACEPT, INC.
    Inventors: Steven M. Toler, David Hosford, Patrick M. Lippiello, Geoffrey Charles Dunbar, William Scott Caldwell, Parviz Hamedani, Merouane Bencherif
  • Publication number: 20120115917
    Abstract: The present invention includes a combination comprising: a) mecamylamine; and b) an ACE inhibitor, an AT2 receptor inhibitor, a renin inhibitor, or a combination thereof.
    Type: Application
    Filed: May 22, 2009
    Publication date: May 10, 2012
    Applicant: Targacept, Inc.
    Inventors: Steven M. Toler, David A. Hosford